MedTrace Logo

Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

NCT00950521 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-04-21

No results posted yet for this study

Summary

The objective of the study is to determine the efficacy of brain transplants of CD34+ stem cells obtained from peripheral blood of patients in the treatment of chronic stroke patients.

Conditions

  • Stroke
  • Middle Cerebral Artery Infarction

Interventions

PROCEDURE

Intercerebral implantation of Autulogous Stem Cells

2-8 millions Stem cell per patients plus convention therapy

DRUG

convention therapy

antiplatelet

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Shinn-Zong Lin, MD, DMSci · China Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00950521 on ClinicalTrials.gov